Logo Lanfrica
  • Home
  • Atlas
  • Insights
  • Docs
  • Sign in

© 2026 Lanfrica. All rights reserved. All copyrights of the resources shown on the Lanfrica website belong to the original copyright holders, unless explicitly stated otherwise.

HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation

Domain:

healthcare

Record type:

paper
Creator:
de LelCarGar
Publisher:
Lip
Host:avatar

Objective: HIV-1 frequently adapts in response to immune pressure from cytotoxic T-lymphocytes (CTL). Many HIV-2 infected individuals have robust capsid-specific CTL responses associated with viral control. Despite this CTL pressure, adaptive changes in this key immunogenic HIV-2 protein have not previously been described. We sought to compare selective pressure on HIV-1 and HIV-2 capsids and identify HLA-associated viral polymorphisms in HIV-2.

Design and methods: Bioinformatic algorithms to identify sites under positive and negative selective pressure and a statistical model of evolution to identify HLA-associated polymorphisms in HIV-2 was applied to sequences from a community cohort in Guinea-Bissau. IFN-γ ELISpots were used to compare T-cell responses to wild-type and variant epitopes.

Results: We identified greater purifying selection and less sites under positive selective pressure in HIV-2 compared to HIV-1. Five HIV-2 codons with HLA-associated polymorphisms were detected all within or around known or predicted CTL epitopes. One site was within the HLA-B58 SuperType (ST)-restricted epitope (TSTVEEQIQW), the HIV-2 equivalent of the HIV-1 TW10 epitope. In contrast to HIV-1, where a T → N mutation at position 3 is associated with resulting loss of CTL control, an E → D mutation at position 5 was observed in HIV-2. Robust CTL responses to the variant HIV-2 epitope were seen, suggesting that HIV-2 adaptation may be at the level of T-cell receptor recognition.

Conclusions: Greater constraints on evolution may exist in HIV-2, resulting in more purifying selection and different immune adaptation pathways in HIV-1 and HIV-2 capsids. This may allow CTL responses to persist in HIV-2.

Visit

ora.ox.ac.uk

Similar

Distinct immune activation and cytokine signatures distinguish HIV-1, HIV-2, and HIV-dual infectionsThe Origin, Evolution, and Epidemiology of HIV-1 and HIV-2Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian medicinal plantsHIV/AIDS 2Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the GambiaDrug resistance mutations and viral load in human immunodeficiency virus type 2 and dual HIV-1/HIV-2 infected patients in Ghana

Distinct immune activation and cytokine signatures distinguish HIV-1, HIV-2, and HIV-dual infections

This dataset consists of metadata for the participants whose blood samples were collected for immuno

The Origin, Evolution, and Epidemiology of HIV-1 and HIV-2

HIV-1 originated in the early 1920s in southern Cameroon and the Democratic Republic of Congo. From

Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian medicinal plants

HIV/AIDS 2

https://www.sil.org/resources/archives/62687

Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia

OBJECTIVES:: This study's objective was to assess outcomes in HIV-1 and HIV-2 infected antiretrovira

Drug resistance mutations and viral load in human immunodeficiency virus type 2 and dual HIV-1/HIV-2 infected patients in Ghana

Abstract Antiretroviral therapy (ART) and drug resistance studies worldwide have focus